Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience

Clin Genitourin Cancer. 2021 Apr;19(2):176-181. doi: 10.1016/j.clgc.2020.10.009. Epub 2020 Nov 12.
No abstract available

Keywords: Immunotherapy; Neuroendocrine cancer; Platinum refractory cancer; Upper tract; Variant histology.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal
  • Humans
  • Immunotherapy
  • Nivolumab
  • Retrospective Studies
  • Urinary Bladder Neoplasms* / therapy

Substances

  • Antibodies, Monoclonal
  • Nivolumab